Late Outcomes for Aortic Valve Replacement With the Carpentier-Edwards Pericardial Bioprosthesis: Up to 17-Year Follow-Up in 1,000 Patients

被引:135
|
作者
McClure, R. Scott
Narayanasamy, Narendren
Wiegerinck, Esther
Lipsitz, Stuart
Maloney, Ann
Byrne, John G.
Aranki, Sary F.
Couper, Gregory S.
Cohn, Lawrence H. [1 ]
机构
[1] Brigham & Womens Hosp, Div Cardiac Surg, Boston, MA 02115 USA
来源
ANNALS OF THORACIC SURGERY | 2010年 / 89卷 / 05期
关键词
20-YEAR EXPERIENCE; DURABILITY;
D O I
10.1016/j.athoracsur.2010.01.046
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. This study reviews a single institution experience with the Carpentier-Edwards pericardial aortic valve bioprosthesis, concentrating on late outcomes. Methods. From December 1991 to June 2002, 1,000 patients underwent aortic valve replacement with the Carpentier-Edwards pericardial valve (mean follow-up 6.01 +/- 3.56 years). The institutional database was reviewed. Follow-up data were acquired through telephone interviews and mail-in questionnaires. Time-toevent analyses were performed by the Kaplan-Meier method. Mean age was 74.1 years; 545 patients (54.5%) were male. Mean preoperative ejection fraction was 52.5%. Isolated aortic valve replacement occurred in 372 cases (37.2%). Combined aortic valve replacement with coronary artery bypass grafting occurred in 443 cases (44.3%). The remaining 185 patients (18.5%) underwent complex procedures with concomitant mitral, tricuspid, or arch repair. One hundred forty patients (14.0%) had prior aortic valve surgery. Follow-up was 99.4% complete. Results. Overall operative mortality was 7.2% (72 of 1,000). There were 503 late deaths (50.3%). Age-stratified survival at 15 years was 43.7% for patients less than 65 years of age; 18.2% for patients aged 65 to 75; and 9.4% for patients aged more than 75 years. There were 26 failed bioprostheses (2.6%) requiring reoperation. Structural valve deterioration was the cause in 13 of 26 cases (50%), endocarditis in 11 of 26 (42%), and perivalvular leak in 2 of 26 (7.6%). Age-stratified freedom from reoperation due to structural valve deterioration at 15 years was 34.7% for patients less than 65 years of age; 89.4% for patients aged 65 to 75; and 99.5% for patients aged more than 75 years. Conclusions. The Carpentier-Edwards pericardial bioprosthesis shows long-term durability with low rates of structural failure. (Ann Thorac Surg 2010;89:1410-6) (C) 2010 by The Society of Thoracic Surgeons
引用
收藏
页码:1410 / 1416
页数:7
相关论文
共 50 条
  • [1] Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations
    Bourguignon, Thierry
    Bouquiaux-Stablo, Anne-Lorraine
    Loardi, Claudia
    Mirza, Alain
    Candolfi, Pascal
    Marchand, Michel
    Aupart, Michel R.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 148 (05): : 2004 - +
  • [2] Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis
    Dellgren, G
    David, TE
    Raanani, E
    Armstrong, S
    Ivanov, J
    Rakowski, H
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 124 (01): : 146 - 154
  • [3] CARPENTIER-EDWARDS BIOPROSTHESIS - A 7-YEAR FOLLOW-UP IN 361 PATIENTS
    ZUSSA, C
    DELPONTE, S
    OTTINO, GM
    PANSINI, S
    ZATTERA, G
    MOREA, M
    THORACIC AND CARDIOVASCULAR SURGEON, 1986, 34 (04): : 252 - 257
  • [4] Late clinical outcomes of aortic valve replacement with Carpentier-Edwards pericardial valves
    Chang, Hyoung Woo
    Kim, Wook Sung
    Ahn, Joong Hyun
    Carriere, Keumhee C.
    Jeong, Dong Seop
    Cho, Yang Hyun
    Sung, Kiick
    Park, Pyo Won
    JOURNAL OF THORACIC DISEASE, 2019, 11 (12) : 5372 - +
  • [5] Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 10-year results
    Murakami, T
    Eishi, K
    Nakano, S
    Kobayashi, J
    Sasako, Y
    Isobe, F
    Kosakai, Y
    Kito, Y
    Kawashima, Y
    JOURNAL OF HEART VALVE DISEASE, 1996, 5 (01): : 45 - 49
  • [6] CARPENTIER-EDWARDS PERICARDIAL BIOPROSTHESIS IN AORTIC POSITION - LONG-TERM FOLLOW-UP 1980 TO 1994
    PELLERIN, M
    MIHAILEANU, S
    COUETIL, JP
    RELLAND, JYM
    DELOCHE, A
    FABIANI, JN
    JINDANI, A
    CARPENTIER, AF
    ANNALS OF THORACIC SURGERY, 1995, 60 (02): : S292 - S296
  • [7] Long-term results of the Carpentier-Edwards pericardial aortic valve: A 12-year follow-up
    Banbury, MK
    Cosgrove, DM
    Lytle, BW
    Smedira, NG
    Sabik, JF
    Saunders, CR
    ANNALS OF THORACIC SURGERY, 1998, 66 (06): : S73 - S76
  • [8] Eight year comparative follow-up after aortic valve replacement with two types of pericardial prosthesis (pericarbon sorin and Carpentier-Edwards)
    Le Tourneau, T
    Granmougin, D
    Hennequin, JL
    Dubar, A
    Warembourg, H
    CIRCULATION, 1998, 98 (17) : 543 - 543
  • [9] Mid-term comparative follow-up after aortic valve replacement with Carpentier-Edwards and Pericarbon pericardial prostheses
    Le Tourneau, T
    Savoye, C
    McFadden, EP
    Grandmougin, D
    Carton, HF
    Hennequin, JL
    Dubar, A
    Fayad, G
    Warembourg, H
    CIRCULATION, 1999, 100 (19) : 11 - 16
  • [10] Thromboembolic events after aortic valve replacement in elderly patients with a Carpentier-Edwards perimount pericardial bioprosthesis
    Mistiaen, W
    Van Cauwelaert, P
    Muylaert, P
    Sys, SU
    Harrisson, F
    Bortier, H
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (04): : 1166 - 1170